Faculty Opinions recommendation of Prophylactic Fentanyl Sublingual Spray for Episodic Exertional Dyspnea in Cancer Patients: A Pilot Double-Blind Randomized Controlled Trial.

Author(s):  
Sebastiano Mercadante
2016 ◽  
Vol 52 (1) ◽  
pp. 8-16.e1 ◽  
Author(s):  
David Hui ◽  
Kelly Kilgore ◽  
Susan Frisbee-Hume ◽  
Minjeong Park ◽  
Anne Tsao ◽  
...  

2017 ◽  
Vol 35 (15_suppl) ◽  
pp. 10110-10110
Author(s):  
Tian Zhou ◽  
Qin Zhou ◽  
Yanbin Wang ◽  
Yingjiang Ye ◽  
Yantao Tian ◽  
...  

10110 Background: Postoperative gastroplegia is common in digestive cancer patients and there were no effective treatments. Gastroplegia Patch is an external-used Chinese Herbal Medicine recipe. It has been applied clinically for more than ten years, which showed good effect. We conducted this study to verify its safety and efficacy on the symptoms of postoperative gastroplegia. Methods: This clinical trial was designed as a multi-center, double-blind, superior effect, randomized controlled trial. It has been registered in ISRCTN (No.18291857) before initiation and was monitored by the third party. Patient inclusion criteria: 1. Gastroenterological cancer patient who was diagnosed as post-surgery gastroplegia, could not eat and need tube feeding (parenteral nutrition or with Jejunum nutrient canal); 2. The local identification of abdomen is cold pattern, which means this kind of patient prefers heat to cold, likes hot food and hates cold ones. Eligible participants were randomized into two arms, placebo arm and Patch arm, respectively. Beside the basic treatments (nutrition support, gastrointestinal decompression, promoting gastric dynamics medicine), placebo or Gastroplegia Patch was applied in control group or Patch group, respectively. Placebos or the patches were allocated at two acupuncture points ( Zhongwan and Shenque). The intervention course was 14 days or reached primary endpoint. The primary endpoint was able to eat without tube feeding. Results: All the 120 eligible participants (60 per arm) were recruited from four AAA hospitals in Beijing, China. Analysis was conducted based on intent-to-treat strategy. After the intervention, 68.33% of the participants in the Patch group were able to eat without tube feeding, which significantly higher than that of 41.67% in the control group (p = 0.003). It took 8 days on average in the Patch group to show effect, which significantly faster than that of 10 days in the control group (p = 0.017). The incidences of adverse events were compatible between the two arms (p = 0.244). Conclusions: Gastroplegia Patch is safe and effective in treating postoperative gastroplegia in gastroenterological cancer patients with cold syndrome. Clinical trial information: 18291857.


2019 ◽  
Vol 133 ◽  
pp. S335-S336
Author(s):  
R. Steenbakkers ◽  
M. Stokman ◽  
R. Kierkels ◽  
M. Schuurman ◽  
A. Van den Hoek ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document